Chinese Volume-Based Procurement Pilot Hits Medtech Stock Prices
The consequences of China’s volume-based, centralized procurement of medical supplies, initiated in 2018, are starting to become clear, according to reports from Omdia.
You may also be interested in...
The recent COVID-19 lockdown in Shanghai caused widespread disruption locally and an economic slowdown for China. But it did not interrupt the ongoing digitization of health care, the value of which was once again thrown into sharp relief, writes news and analysis portal Omdia.
The key health care and infrastructure trends in China and how they will affect the local medtech market and industry are listed by Medtech Insight’s sister news portal, Omdia.
China has released a five-year plan for the development of the robotics industry. Health care applications are a key part of that plan, according to reports from Omdia.